Proscia®, a global leader in AI-enabled pathology solutions for precision medicine, today announced the launch of Concentriq® Embeddings and the Proscia AI Toolkit, enabling life sciences organizations to accelerate the discovery and development of novel therapies and diagnostics.
Proscia Launches Concentriq Embeddings and Developer Toolkit to Unleash Pathology AI Development
October 3, 2024 by
Proscia Strengthens Leadership Position In AI-enabled Diagnostic Pathology Market
July 10, 2024 by
Proscia®, a global leader in AI-enabled pathology solutions for precision medicine, has expanded its leadership position in the diagnostic pathology market. The company has grown its clinical customer base by more than 100% in the past year. Among its other highlights, Proscia was recognized by KLAS Research in a June 2024 Emerging Company Spotlight report and released findings from a study conducted with Quest Diagnostics, a leading provider of diagnostic information services, on the impact of its AI-enabled workflows.
Deep Learning in HPC – Using Data to Go Far Beyond Automation in Pathology
January 29, 2017 by
Dr. Amit Seti from IIT-Gauwhati presented this talk at GTCx in India. “This talk will cover how medical imaging data can be used to train computer vision systems that automate diagnostic analysis in current clinical practice. Not only that, with more creative use of data, we can go even beyond that to predict outcome of specific treatment for individual patients. We will cover results from prostate and breast cancers to show that a future is not too far where algorithms will become a necessary set of tools in a pathologist’s toolbox.”
